Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients (Q40869186)
Jump to navigation
Jump to search
scientific article published on 14 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients |
scientific article published on 14 January 2016 |
Statements
1 reference
Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients (English)
1 reference
Lixin Guo
1 reference
Xiaohui Guo
1 reference
Yan Li
1 reference
Xu Hong
1 reference
Xiaozhen Jiang
1 reference
Qing Su
1 reference
Dong Zhao
1 reference
Xiaojing Wu
1 reference
Linong Ji
1 reference
14 January 2016
1 reference
1 reference
10
1 reference
3
1 reference
137-142
1 reference
Identifiers
1 reference
1 reference